Biochemical markers of autism

Close metadata

Recommended articles:

Controversial issues of diagnosis and theoretical concepts of schizophrenia in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):17-24

The role of immuno-inflammatory factors in the development of negative symptoms in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48

Treatment of atopic dermatitis considering assessment of neurotransmitters in blood. Russian Journal of Clinical Dermatology and Venereology. 2024;(4):368-376

Modern scientific and practical approaches to searching for biomarkers of aging. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(3):46-52

Prognostic scale for early detection of various postoperative complications after thoracic aortic surgery: post-hoc analysis of biomarkers. Pirogov Russian Journal of Surgery. 2024;(10):38-48

New aspects of psoriasis pathogenesis: metabolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Venereology. 2024;(5):526-531

Laboratory biomarkers for the prognosis of chronic heart failure. Laboratory Service. 2024;(3):5-16

Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medicine. 2024;(12):145-150

Prognosis and prevention of recurrent and atypical endometrial hyperplasia in women of reproductive age. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):59-65

Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medicine. 2025;(1):89-95

Autism spectrum disorder (ASD) is becoming an increasingly common disorder of the development of the nervous system in the modern world. The diagnosis is made based on observation of the patient’s behavior, which significantly complicates the diagnosis and treatment of the disorder. The subjectivity of behavioral diagnostics dictates the need for the study of biomarkers of ASD. Over the past two decades, researchers have focused on identifying specific biological abnormalities in ASD that will help in the diagnosis of the disease. This review discusses the state of research on various biomarkers currently being developed for ASD.

Keywords:

autism

biomarkers

Authors:

Samoilova I.G.

Siberian State Medical University

ORCID: 0000-0003-2660-469X

Matveeva M.V.

Siberian State Medical University

SPIN RSCI: 3913-5419
Scopus AuthorID: 633358
ORCID: 0000-0001-9966-6686

Galyukova D.E.

Siberian State Medical University

ORCID: 0000-0003-2660-469X

Received:

31.08.2023

Accepted:

07.10.2023

List of references:

World Health Organization, ICD-10: International Statistical Classification of Diseases and Related Health Problems 10th Revision 1992. https://icd.who.int/en
Kazakovtsev BA, Demcheva NK, Yazdovskaya AV, et al. Psikhiatricheskaya Pomoshch Naseleniyu Rossiiskoi Federatsii V 2019 Godu: Analiticheskii Obzor. M.: FGBU «NMITsPN im. V.P. Serbskogo» Minzdrava Rossii. 2020. (In Russ.).
Zeidan J, Fombonne E, Scorah J, et al. Global Prevalence of Autism: A Systematic Review Update. Autism Research. 2022;15(5):778-790. https://doi.org/10.1002/aur.2696
El-Ansary A, Chirumbolo S, Bhat RS, et al. The Role of Lipidomics in Autism Spectrum Disorder. Mol Diagn Ther. 2020;24(1):31-48. https://doi.org/10.1007/S40291-019-00430-0
Prata J, Machado AS, von Doellinger O, et al. The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence. Methods Mol Biol. 2019;2011:493-510. https://doi.org/10.1007/978-1-4939-9554-7_29
Ren K, Dubner R. Interactions between the Immune and Nervous Systems in Pain. Nat Med. 2010;16(11):1267-1276. https://doi.org/10.1038/Nm.2234
Chez MG, Dowling T, Patel PB, et al. (2007) Elevation of Tumor Necrosis Factor-Alpha in Cerebrospinal Fluid of Autistic Children. Pediatr Neurol. 2007;36(6):361-365. https://doi.org/10.1016/j.Pediatrneurol.2007.01.012
Olmos G, Lladó J. Tumor Necrosis Factor Alpha: A Link between Neuroinflammation and Excitotoxicity. Mediators Inflamm. 2014;2014:861231. https://doi.org/10.1155/2014/861231
Li X, Chauhan A, Sheikh AM, Patil S, et al. Elevated Immune Response in the Brain of Autistic Patients. J Neuroimmunol. 2009;207(1-2):111-116. https://doi.org/10.1016/j.Jneuroim.2008.12.002
Xie J, Huang L, Li X, et al. Immunological Cytokine Profiling Identifies TNF-α as a Key Molecule Dysregulated in Autistic Children. Oncotarget. 2017;8(47):82390-82398. https://doi.org/10.18632/Oncotarget.19326
Ghaffari MA. Mousavinejad E, Riahi F, et al. Increased Serum Levels of Tumor Necrosis Factor-Alpha, Resistin, and Visfatin in the Children with Autism Spectrum Disorders: A Case-Control Study. Neurology Research International. 2016;2016:9060751. https://doi.org/10.1155/2016/9060751
Guloksuz SA, Abali O, Aktas Cetin E, et al. Elevated Plasma Concentrations of S100 Calcium-Binding Protein B and Tumor Necrosis Factor Alpha in Children with Autism Spectrum Disorders. Braz J Psychiatry. 2017;39(3):195-200. https://doi.org/10.1590/1516-4446-2015-1843
Jensen AR, Lane AL, Werner BA, et al. Modern Biomarkers for Autism Spectrum Disorder: Future Directions. Mol Diagn Ther. 2022;26(5):483-495. https://doi.org/10.1007/S40291-022-00600-7
Goines PE, Croen LA, Braunschweig D, et al. Increased Midgestational IFN-γ, IL-4 and IL-5 in Women Bearing a Child with Autism: A Case-Control Study. Mol Autism. 2011;2:13. https://doi.org/10.1186/2040-2392-2-13
Han X. Lipidomics for Studying Metabolism. Nat Rev Endocrinol. 2016;12(11):668-679. https://doi.org/10.1038/Nrendo.2016.98
Gloyn AL, Faber JH, Malmodin D, et al. Thanabalasingham G, Lam F, Ueland PM, McCarthy MI, Owen KR, Baunsgaard D. Metabolic Profiling in Maturity-Onset Diabetes of the Young (MODY) and Young Onset Type 2 Diabetes Fails to Detect Robust Urinary Biomarkers. PLoS One. 2012;7(7):E40962. https://doi.org/10.1371/Journal.Pone.0040962
Rauschert S, Uhl O, Koletzko B, et al. Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults. J Clin Endocrinol Metab. 2016;101(3):871-879. https://doi.org/10.1210/Jc.2015-3525
Yu D, Shu XO, Rivera ES, et al. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults. J Am Heart Assoc. 2019;8(1):E010606. https://doi.org/10.1161/JAHA.118.010606
Tallberg T, Dabek J, Hallamaa R, Atroshi F. Lipidomics: the function of vital lipids in embryogenesis preventing autism spectrum disorders, treating sterile inflammatory diatheses with a lymphopoietic central nervous system component. J Lipids. 2011;2011:137175. https://doi.org/10.1155/2011/137175
Bazinet RP, Layé S. Polyunsaturated Fatty Acids and Their Metabolites in Brain Function and Disease. Nat Rev Neurosci. 2014;15(12):771-785. https://doi.org/10.1038/Nrn3820
Petrov AM, Kasimov MR, Zefirov AL. Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction. Acta Naturae. 2017;9(1):26-37.
Gillberg C, Fernell E, Kočovská E, et al. The Role of Cholesterol Metabolism and Various Steroid Abnormalities in Autism Spectrum Disorders: A Hypothesis Paper. Autism Res. 2017;10(6):1022-1044. https://doi.org/10.1002/Aur.1777
Björkhem I. Crossing the Barrier: Oxysterols as Cholesterol Transporters and Metabolic Modulators in the Brain. J Intern Med. 2006;260(6):493-508. https://doi.org/10.1111/j.1365-2796.2006.01725.x
Grayaa S, Zerbinati C, Messedi M, et al. Plasma Oxysterol Profiling in Children Reveals 24-Hydroxycholesterol as a Potential Marker for Autism Spectrum Disorders. Biochimie. 2018;153:80-85. https://doi.org/10.1016/j.Biochi.2018.04.026
Kałużna-Czaplińska J, Żurawicz E, Jóźwik J. Chromatographic Techniques Coupled with Mass Spectrometry for the Determination of Organic Acids in the Study of Autism. Journal of Chromatography B. 2014;964:128-135. https://doi.org/10.1016/j.jchromb.2013.10.026
Kałużna-Czaplińska J, Socha E, Rynkowski J. B Vitamin Supplementation Reduces Excretion of Urinary Dicarboxylic Acids in Autistic Children. Nutr Res. 2011;31(7):497-502. https://doi.org/10.1016/j.Nutres.2011.06.002
Puig-Alcaraz C, Fuentes-Albero M, Cauli O. Relationship between Adipic Acid Concentration and the Core Symptoms of Autism Spectrum Disorders. Psychiatry Res. 2016;242:39-45. https://doi.org/10.1016/j.Psychres.2016.05.027
Hill AP, Zuckerman KE, Fombonne E. Obesity and Autism. Pediatrics. 2015;136(6):1051-1061. https://doi.org/10.1542/peds.2015-1437
Broder-Fingert S, Brazauskas K, Lindgren K, et al. Prevalence of Overweight and Obesity in a Large Clinical Sample of Children with Autism. Academic Pediatrics. 2014;14(4):408-414. https://doi.org/10.1016/j.acap.2014.04.004
Skalny AV, Skalnaya MG, Bjørklund G, et al. Mercury as a Possible Link between Maternal Obesity and Autism Spectrum Disorder. Med Hypotheses. 2016;91:90-94. https://doi.org/10.1016/j.Mehy.2016.04.021
Surén P, Gunnes N, Roth C, Bresnahan M, et al. Parental Obesity and Risk of Autism Spectrum Disorder. Pediatrics. 2014;133(5):E1128-1138. https://doi.org/10.1542/Peds.2013-3664
Riikonen R, Makkonen I, Vanhala R, et al. Cerebrospinal Fluid Insulin-like Growth Factors IGF-1 and IGF-2 in Infantile Autism. Dev Med Child Neurol. 2006;48(9):751-755. https://doi.org/10.1017/S0012162206001605
Mills JL, Hediger ML, Molloy CA, et al. Elevated Levels of Growth-Related Hormones in Autism and Autism Spectrum Disorder. Clin Endocrinol (Oxf). 2007;67(2):230-237. https://doi.org/10.1111/j.1365-2265.2007.02868.x
Mraz KD, Dixon J, Dumont-Mathieu T, Fein D. Accelerated Head and Body Growth in Infants Later Diagnosed with Autism Spectrum Disorders: A Comparative Study of Optimal Outcome Children. J Child Neurol. 2009;24(7):833-845. https://doi.org/10.1177/0883073808331345
Modahl C, Green L, Fein D, et al. Plasma Oxytocin Levels in Autistic Children. Biol Psychiatry. 1998;43(4):270-277. https://doi.org/10.1016/S0006-3223(97)00439-3
Hollander E, Novotny S, Hanratty M, et al. Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger’s Disorders. Neuropsychopharmacology. 2003;28(1):193-198. https://doi.org/10.1038/Sj.Npp.1300021
Egashira N, Mishima K, Iwasaki K, et al. New Topics in Vasopressin Receptors and Approach to Novel Drugs: Role of the Vasopressin Receptor in Psychological and Cognitive Functions. J Pharmacol Sci. 2009;109(1):44-49. https://doi.org/10.1254/Jphs.08r14fm
Boso M, Emanuele E, Politi P, et al. Reduced Plasma Apelin Levels in Patients with Autistic Spectrum Disorder. Arch Med Res. 2007;38(1):70-74. https://doi.org/10.1016/j.Arcmed.2006.08.003
Chen J, Xin K, Wei J, et al. Lower Maternal Serum 25(OH) D in First Trimester Associated with Higher Autism Risk in Chinese Offspring. J Psychosom Res. 2016;89:98-101. https://doi.org/10.1016/j.Jpsychores.2016.08.013
Vinkhuyzen AAE, Eyles DW, Burne THJ, et al. Gestational Vitamin D Deficiency and Autism Spectrum Disorder. BJPsych Open. 2017;3(2):85-90. https://doi.org/10.1192/Bjpo.Bp.116.004077
Magnusson C, Lundberg M, Lee BK, et al. Maternal Vitamin D Deficiency and the Risk of Autism Spectrum Disorders: Population-Based Study. BJPsych Open. 2016;2(2):170-172. https://doi.org/10.1192/Bjpo.Bp.116.002675
El-Ansary A, Bjørklund G, Tinkov AA, et al. Relationship between Selenium, Lead, and Mercury in Red Blood Cells of Saudi Autistic Children. Metab Brain Dis. 2017;32(4):1073-1080. https://doi.org/10.1007/S11011-017-9996-1
Zhang J, Li X, Shen L, et al. Trace Elements in Children with Autism Spectrum Disorder: A Meta-Analysis Based on Case-Control Studies. J Trace Elem Med Biol. 2021;67:126782. https://doi.org/10.1016/j.Jtemb.2021.126782
Li SO, Wang JL, Bjørklund G, et al. Serum Copper and Zinc Levels in Individuals with Autism Spectrum Disorders. Neuroreport. 2014;25(15):1216-1220. https://doi.org/10.1097/WNR.0000000000000251
Bjorklund G. The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars). 2013;73(2):225-236.
Rossignol DA, Frye RE. Mitochondrial Dysfunction in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. Mol Psychiatry. 2012;17(3):290-314. https://doi.org/10.1038/Mp.2010.136
Weissman JR, Kelley RI, Bauman ML, et al. Mitochondrial Disease in Autism Spectrum Disorder Patients: A Cohort Analysis. PLoS One. 2008;3(11):E3815. https://doi.org/10.1371/Journal.Pone.0003815
Goldenthal MJ, Damle S, Sheth S, et al. Mitochondrial Enzyme Dysfunction in Autism Spectrum Disorders; a Novel Biomarker Revealed from Buccal Swab Analysis. Biomark Med. 2015;9(10):957-965. https://doi.org/10.2217/Bmm.15.72
Goh S, Dong Z, Zhang Y, et al. Mitochondrial Dysfunction as a Neurobiological Subtype of Autism Spectrum Disorder: Evidence From Brain Imaging. JAMA Psychiatry. 2014;71(6):665-671. https://doi.org/10.1001/Jamapsychiatry.2014.179

Close metadata